We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

UK Judge Nixes Patent Extension For Merck HIV Drug

Law360, New York (March 22, 2017, 7:52 PM EDT) -- A U.K. judge on Tuesday ruled that a Merck Sharp & Dohme Corp. document extending a patent on the HIV drug Atripla is invalid, in a win for generics makers Teva...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.